REQUEST A DEMO
Total
USD $0.00
Search more companies

Laboratorio De Citologia Y Patologia Cypat S.A.S. (Colombia)

Main Activities: Diagnostic Imaging Centers
Secondary Activities: Machinery, Equipment, and Supplies Merchant Wholesalers
Full name: Laboratorio De Citologia Y Patologia Cypat S.A.S. Profile Updated: September 25, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Spanish Download a sample report

Laboratorio De Citologia Y Patologia Cypat S.A.S. is an enterprise in Colombia, with the main office in Bucaramanga. It operates in the Diagnostic Imaging Centers sector. It was incorporated on October 02, 2012. The latest financial highlights indicate a net sales revenue increase of 13.26% in 2023. Its’ total assets recorded a growth of 2.83%. The net profit margin of Laboratorio De Citologia Y Patologia Cypat S.A.S. decreased by 6.34% in 2023.

Headquarters
Calle 46 # 35 A - 06 Edificio Central Pa
Bucaramanga; Santander;

Contact Details: Purchase the Laboratorio De Citologia Y Patologia Cypat S.A.S. report to view the information.

Basic Information
Outstanding Shares:
Purchase the Laboratorio De Citologia Y Patologia Cypat S.A.S. report to view the information.
Incorporation Date:
October 02, 2012
Key Executives
Purchase this report to view the information.
Legal Representative
Company Performance
Financial values in the chart are available after Laboratorio De Citologia Y Patologia Cypat S.A.S. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency COP. Absolute financial data is included in the purchased report.
Net sales revenue
13.26%
Total operating revenue
13.26%
Operating profit (EBIT)
8.69%
EBITDA
6.8%
Net Profit (Loss) for the Period
-29.39%
Total assets
2.83%
Total equity
0.11%
Operating Profit Margin (ROS)
-0.92%
Net Profit Margin
-6.34%
Return on Equity (ROE)
-9.2%
Quick Ratio
-4.4%
Cash Ratio
0.16%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?